Trials / Conditions / Stage III Follicular Thyroid Cancer

Stage III Follicular Thyroid Cancer

3 registered clinical trials studyying Stage III Follicular Thyroid Cancer.

Status	Trial	Sponsor	Phase
Terminated	Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer NCT00095693	National Cancer Institute (NCI)	Phase 2
Completed	Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Can NCT00068497	National Cancer Institute (NCI)	N/A
Completed	Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074	National Cancer Institute (NCI)	Phase 1